| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3876541 | The Journal of Urology | 2008 | 6 Pages |
Abstract
Norfloxacin and amikacin could be used for initial therapy for P. aeruginosa mediated respiratory tract infections. Amikacin, meropenem and norfloxacin could be used for P. aeruginosa mediated urinary tract and skin infections. Such studies are essential to determine the current guidelines for empirical therapy regimens, which vary by location, and help with the establishment of effective infection control measures.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Gamal F. Gad, Ramadan A. El-Domany, Hossam M. Ashour,